This small biotech could grow much larger with some good news from its pipeline.
While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Investor's Business Daily on MSN
Stock market today: Dow dips on Trump Iran move; biotech plays, these software stocks shine (live coverage)
Stock Market Today: The Dow Jones fell on President Trump's latest Iran move. Software stocks and biotech shined but Goldman Sachs fell.
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...
Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Revolution Medicines (RVMD) is one of the best stocks on Wall Street today after breakthrough cancer pill results ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...
As a result, since the start of the year, two formerly down-and-out stocks in these industries are outperforming the S&P 500.
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results